Overview
Background
Profile Summary
Dr Sandro Porceddu is an internationally recognised radiation oncologist and a leading authority in head and neck and skin cancer. With over 20 years experience in medicine his areas of clinical expertise include head and neck cancer, skin cancer, sarcoma and lymphoma. He is currently a senior radiation oncologist and Director of radiation oncology research at the Princess Alexandra Hospital, Brisbane, Professor of Medicine, University of Queensland and Associate Editor for the International Head and Neck journal, Oral Oncology.
Dr Porceddu is a nationally and internationally recognised cancer advocate through his involvement in high-level committees, engagement with key policymakers, community education and media roles.
Career Summary
Professor Porceddu completed his medical degree at Monash University before undertaking his residency at Monash Medical Centre, Melbourne. He commenced his specialist training in radiation oncology at the Peter MacCallum Cancer Centre in 1996 and was made Fellow of the Royal Australian and New Zealand College of Radiologists, Faculty of Radiation Oncology in 2000. After working as a consultant radiation oncologist at PeterMac for several years he moved to the Princess Alexandra Hospital in 2004.
Professional Committees and Organisations
Professor Porceddu has been the President of the Clinical Oncology Society of Australia (COSA), the peak organisation for cancer-related health professionals, and the Trans Tasman Radiation Oncology Group (TROG), one of the largest cancer collaborative trials group in Australia/New Zealand. He has served on numerous national and international professional and academic committees including the board of the Cancer Council of Australia, the National Cancer Expert Reference Group for the Commonwealth and the International Union for the Control of Cancer (UICC) TNM Expert Advisory Panel.
Currently, he is the Chair of the Cancer Council Queensland Co-operative Oncology Group, a committee that provides over $1.2M per annum to support clinical research throughout Queensland and is on the board of the of the Head and Neck Cancer InterGroup (HNCIG), a group of leading world cancer experts dedicated to promoting the global harmonisation of head and neck cancer research and treatment.
Academic Highlights
Professor Porceddu runs an active clinical research program with over 150 peer-review articles, book chapters, published abstracts, invited reviews and commentaries. He has received invitations to speak at major international conferences such as the American Society of Clinical Oncology (ASCO) meeting and publish in prestigious journals such as the Lancet Oncology and Journal of Clinical Oncology.
Awards
Trans Tasman Radiation Oncology Group Outstanding Contribution
American Head and Neck Society Chris O’Brien Travelling Scholar
Pre-eminent status by Queensland Health
Rouse Fellowship, Royal Australian and New Zealand College of Radiologists
Teaching
Dr Porceddu has had a life-long commitment to teaching and is a supervisor and mentor to Doctor of Philosophy and Master of Philosophy candidates, Clinical Research Fellows, MBBS Honours students, resident, registrars and other allied health professionals.
Availability
- Professor Sandro Porceddu is:
- Available for supervision
Fields of research
Qualifications
- Bachelor of Science, Monash University
- Bachelor of Medicine and Surgery and Medical Science, Monash University
- Doctoral Diploma of Medicine, The University of Queensland
Research impacts
Dr Porceddu’s has been investigating methods to reduce the morbidity of treatment, improve cure rates and quality of life for cancer patients. He runs an active head and neck/skin cancer research program and is the principal investigator of numerous trials including an NHMRC-supported Randomised Phase III trial on head and neck skin cancer (POST TROG 05.01). In line with his research goals he has been examining the integration of radiation therapy and new technologies in the management of head and neck cancer and has received his Doctorate of Medicine (MD) on this topic with UQ. His current research on Positron Emission Tomography in the management of the neck following chemo-radiotherapy has been internationally recognised and incorporated into the USA National Comprehensive Cancer Network (NCCN) guidelines. He has been the recipient of over $3.91M in competitive funding, including one recently closed and two open NHMRC grants.
Works
Search Professor Sandro Porceddu’s works on UQ eSpace
2025
Journal Article
Predictors of distant metastatic recurrence in head and neck cutaneous squamous cell carcinoma with lymph node metastases treated with curative intent: A multicenter study
Ebrahimi, Ardalan, Gupta, Ruta, Mcdowell, Lachlan, Magarey, Matthew J. R., Smith, Paul N., Schulte, Klaus-Martin, Perriman, Diana M., Veness, Michael, Porceddu, Sandro, Low, Tsu-Hui Hubert, Fowler, Allan and Clark, Jonathan R. (2025). Predictors of distant metastatic recurrence in head and neck cutaneous squamous cell carcinoma with lymph node metastases treated with curative intent: A multicenter study. Head and Neck-Journal for the Sciences and Specialties of the Head and Neck, 47 (1), 254-262. doi: 10.1002/hed.27912
2024
Journal Article
Geospatial analyses demonstrate variation of cutaneous T-cell lymphomas across Australia, providing insights into possible causes
Campbell, Belinda A., Baade, Peter D., Dasgupta, Paramita, Cameron, Jessica K., Porceddu, Sandro V., Prince, H. Miles and Thursky, Karin (2024). Geospatial analyses demonstrate variation of cutaneous T-cell lymphomas across Australia, providing insights into possible causes. British Journal of Dermatology ljae476. doi: 10.1093/bjd/ljae476
2024
Journal Article
Determinants of Prognosis in Head and Neck Cutaneous Squamous Cell Carcinoma With Nodal Metastases
Ebrahimi, Ardalan, Gupta, Ruta, McDowell, Lachlan, Magarey, Matthew J. R., Smith, Paul N., Schulte, Klaus-Martin, Perriman, Diana M., Veness, Michael, Porceddu, Sandro, Low, Tsu-Hui Hubert, Fowler, Allan and Clark, Jonathan R. (2024). Determinants of Prognosis in Head and Neck Cutaneous Squamous Cell Carcinoma With Nodal Metastases. Jama Otolaryngology-Head & Neck Surgery, 150 (11), e1-e9. doi: 10.1001/jamaoto.2024.3103
2024
Conference Publication
A phase 1 clinical trial of DB-020 intratympanic injections administered prior to high-dose cisplatin chemotherapy to reduce ototoxicity
Panizza, Benedict J., O'Leary, Stephen John, Hart, Christopher David, Diwakarla, Chandra Sai, Barnett, Catherine, Lapuerta, Pablo, Lee, John, Raines, Shane, Quigley, Tera, Wolff, Heather M., Keilty, John, Ladwa, Rahul, Porceddu, Sandro V., McGrath, Margaret, Seetharamu, Nagashree, Fua, Tsien and Rischin, Danny (2024). A phase 1 clinical trial of DB-020 intratympanic injections administered prior to high-dose cisplatin chemotherapy to reduce ototoxicity. 2024 ASCO Annual Meeting, Chicago, IL United States, 31 May - 4 June 2024. Alexandria, VA United States: American Society of Clinical Oncology. doi: 10.1200/jco.2024.42.16_suppl.6100
2024
Journal Article
Human papillomavirus associated oropharyngeal cancer now the most common mucosal head and neck cancer in Queensland
Porceddu, Sandro, Negrello, Theresa, Rawson, Neal, Dunn, Nathan, Batstone, Martin, Collins, Michael, Dowthwaite, Sam, Hughes, Brett G. M., Kenny, Liz, Ladwa, Rahul, Panizza, Ben and Cossio, Danica (2024). Human papillomavirus associated oropharyngeal cancer now the most common mucosal head and neck cancer in Queensland. Journal of Medical Imaging and Radiation Oncology, 68 (4), 472-480. doi: 10.1111/1754-9485.13643
2024
Journal Article
Characterising B cell expression and prognostic significance in human papillomavirus positive oropharyngeal cancer
Young, Richard J., Angel, Christopher, Bressel, Mathias, Pizzolla, Angela, Thai, Alesha A., Porceddu, Sandro V., Liu, Howard, Idrizi, Rejhan, Metta, Jana, Lim, Annette M., Solomon, Benjamin J. and Rischin, Danny (2024). Characterising B cell expression and prognostic significance in human papillomavirus positive oropharyngeal cancer. Oral Oncology, 150 106687. doi: 10.1016/j.oraloncology.2024.106687
2023
Conference Publication
High-plex spatial profiling of cutaneous squamous cell carcinoma to identify biomarkers associated with clinical outcomes: The cMIC study
Ladwa, R., Monkman, J., Sadeghirad, H., Cooper, C., Belz, G., Bowman, J., Schaider, H., Liu, H., Kulasinghe, A. and Porceddu, S. (2023). High-plex spatial profiling of cutaneous squamous cell carcinoma to identify biomarkers associated with clinical outcomes: The cMIC study. ESMO Congress 2023, Madrid, Spain, 20-24 October 2023. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.annonc.2023.09.2278
2023
Journal Article
Patient-Reported Symptom Severity, Health-Related Quality of Life, and Emotional Distress Trajectories During and After Radiation Therapy for Human Papillomavirus–Associated Oropharyngeal Cancer: A TROG 12.01 Secondary Analysis
McDowell, Lachlan, Bressel, Mathias, King, Madeleine T., Corry, June, Kenny, Lizbeth, Porceddu, Sandro, Wratten, Christopher, Macann, Andrew, Jackson, James E. and Rischin, Danny (2023). Patient-Reported Symptom Severity, Health-Related Quality of Life, and Emotional Distress Trajectories During and After Radiation Therapy for Human Papillomavirus–Associated Oropharyngeal Cancer: A TROG 12.01 Secondary Analysis. International Journal of Radiation Oncology Biology Physics, 116 (5), 1110-1125. doi: 10.1016/j.ijrobp.2023.02.041
2023
Conference Publication
A proteomic signature associated with prognosis in HPV-related locally advanced oropharyngeal squamous cell carcinoma (LA-OPSCC)
Liu, Jia (Jenny), Jackson, Christopher, Anees, Asim, Noor, Zainab, Williams, Steven, Porceddu, Sandro, Liu, Howard, Ladwa, Rahul, Whitfield, Joseph, Reddel, Roger R., Zhong, Qing, Panizza, Benedict J. and Robinson, Phillip J (2023). A proteomic signature associated with prognosis in HPV-related locally advanced oropharyngeal squamous cell carcinoma (LA-OPSCC). 2023 ASCO Annual Meeting, Chicago, IL United States, 2-6 June 2023. Alexandria, VA United States: American Society of Clinical Oncology. doi: 10.1200/jco.2023.41.16_suppl.6055
2023
Journal Article
The Current Treatment Landscape of Cutaneous Squamous Cell Carcinoma
Chong, Chia Yuen, Goh, Michelle S., Porceddu, Sandro V., Rischin, Danny and Lim, Annette M. (2023). The Current Treatment Landscape of Cutaneous Squamous Cell Carcinoma. American Journal of Clinical Dermatology, 24 (1), 25-40. doi: 10.1007/s40257-022-00742-8
2023
Book Chapter
Regional radiotherapy in head and neck non-melanoma skin cancer
Smith, Justin and Porceddu, Sandro V. (2023). Regional radiotherapy in head and neck non-melanoma skin cancer . Radiotherapy in skin cancer: a practical guide on indications and techniques. (pp. 145-152) edited by Kurian Jones Joseph, Michael J. Veness, Elizabeth Barnes and Agata Rembielak. Cham, Switzerland: Springer International Publishing. doi: 10.1007/978-3-031-44316-9_14
2022
Journal Article
HPV status represents dominant trait driving delineation of survival-associated gene co-expression networks in head and neck cancer
Mehdi, Ahmed M., Zhou, Chenhao, Turrell, Gavin, Walpole, Euan, Porceddu, Sandro, Frazer, Ian H. and Chandra, Janin (2022). HPV status represents dominant trait driving delineation of survival-associated gene co-expression networks in head and neck cancer. Cancer Gene Therapy, 30 (4), 1-12. doi: 10.1038/s41417-022-00577-9
2022
Conference Publication
High-dimensional spatial phenotyping of cutaneous squamous cell carcinoma from immune-competent and immunocompromised patients
Kulasinghe, Arutha, Jhaveri, Niyati, Klymyshyn, Dmytro, Cheikh, Bassem Ben, Ladwa, Rahul, Liu, Howard, Cooper, Caroline, Belz, Gabrielle, Porceddu, Sandro and Braubach, Oliver (2022). High-dimensional spatial phenotyping of cutaneous squamous cell carcinoma from immune-competent and immunocompromised patients. SITC 37th Annual Meeting (SITC 2022), Boston, MA United States, 8–12 November 2022. London, United Kingdom: BMJ Group. doi: 10.1136/jitc-2022-sitc2022.0079
2022
Journal Article
Evolution of head and neck cutaneous squamous cell carcinoma nodal staging — an Australian perspective
Hurrell, Michael J. L., Low, Tsu-Hui, Ebrahimi, Ardalan, Veness, Michael, Ashford, Bruce, Porceddu, Sandro and Clark, Jonathan R. (2022). Evolution of head and neck cutaneous squamous cell carcinoma nodal staging — an Australian perspective. Cancers, 14 (20) 5101, 1-15. doi: 10.3390/cancers14205101
2022
Journal Article
A prospective observational cohort study examining the development of head and neck lymphedema from the time of diagnosis
Pigott, Amanda, Brown, Bena, White, Nicole, McPhail, Steven, Porceddu, Sandro, Liu, Howard, Jeans, Claire, Panizza, Ben and Nixon, Jodie (2022). A prospective observational cohort study examining the development of head and neck lymphedema from the time of diagnosis. Asia-Pacific Journal of Clinical Oncology, 19 (4), 473-481. doi: 10.1111/ajco.13843
2022
Journal Article
Epidemiology and treatment outcomes of cutaneous squamous cell carcinoma extending to the temporal bone
Schachtel, Michael J. C., Gandhi, Mitesh, Bowman, James J., Porceddu, Sandro V. and Panizza, Benedict J. (2022). Epidemiology and treatment outcomes of cutaneous squamous cell carcinoma extending to the temporal bone. Head and Neck, 44 (12), 2727-2743. doi: 10.1002/hed.27185
2022
Journal Article
Immunotherapy for the treatment of perineural spread in cutaneous head and neck squamous cell carcinoma: time to rethink treatment paradigms
Nightingale, James, Gandhi, Mitesh, Helena, Jonathan, Bowman, James, McGrath, Margaret, Coward, Jermaine, Porceddu, Sandro, Ladwa, Rahul and Panizza, Benedict (2022). Immunotherapy for the treatment of perineural spread in cutaneous head and neck squamous cell carcinoma: time to rethink treatment paradigms. Head and Neck, 44 (5), 1099-1105. doi: 10.1002/hed.27005
2022
Journal Article
Influence of Treatment Package Time on outcomes in High-Risk Oral Cavity Carcinoma in patients receiving Adjuvant Radiation and Concurrent Systemic Therapy: A Multi-Institutional Oral Cavity Collaborative study
Ghanem, Ahmed I., Woody, Neil M., Schymick, Mathew A., Joshi, Nikhil P., Geiger, Jessica L., Jillian Tsai, Chiaojung, Dunlap, Neal E., Liu, Howard Y., Burkey, Brian B., Lamarre, Eric D., Ku, Jamie A., Scharpf, Joseph, Caudell, Jimmy J., Porceddu, Sandro V., Lee, Nancy Y., Adelstein, David J., Koyfman, Shlomo A. and Siddiqui, Farzan (2022). Influence of Treatment Package Time on outcomes in High-Risk Oral Cavity Carcinoma in patients receiving Adjuvant Radiation and Concurrent Systemic Therapy: A Multi-Institutional Oral Cavity Collaborative study. Oral Oncology, 126 105781, 1-7. doi: 10.1016/j.oraloncology.2022.105781
2022
Journal Article
Facial nerve perineural spread from cutaneous squamous cell carcinoma of the head and neck: a single institution analysis of epidemiology, treatment, survival outcomes, and prognostic factors
Schachtel, Michael J. C., Gandhi, Mitesh, Bowman, James J., Porceddu, Sandro V. and Panizza, Benedict J. (2022). Facial nerve perineural spread from cutaneous squamous cell carcinoma of the head and neck: a single institution analysis of epidemiology, treatment, survival outcomes, and prognostic factors. Head and Neck, 44 (5), 1223-1236. doi: 10.1002/hed.27017
2022
Journal Article
Prognostic stratification of HPV-associated oropharyngeal cancer based on CD103+ immune cell abundance in patients treated on TROG 12.01 and De-ESCALaTE randomized trials
Rischin, D., Mehanna, H., Young, R. J., Bressel, M., Dunn, J., Corry, J., Soni, P., Fulton-Lieuw, T., Iqbal, G., Kenny, L., Porceddu, S., Wratten, C., Robinson, M., Solomon, B. J. and on behalf of theTrans-Tasman Radiation Oncology Group and the De-ESCALaTE HPV Trial Group (2022). Prognostic stratification of HPV-associated oropharyngeal cancer based on CD103+ immune cell abundance in patients treated on TROG 12.01 and De-ESCALaTE randomized trials. Annals of Oncology, 33 (8), 804-813. doi: 10.1016/j.annonc.2022.04.074
Funding
Past funding
Supervision
Availability
- Professor Sandro Porceddu is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Supervision history
Completed supervision
-
2017
Master Philosophy
Pre-radiotherapy dental extractions and osteoradionecrosis: a retrospective analysis and cross-sectional study on quality of life
Associate Advisor
-
2012
Doctor Philosophy
Swallowing, nutrition, and patient-rated functional outcomes in head and neck cancer patients treated with altered fractionation radiotherapy
Associate Advisor
Other advisors: Professor Elizabeth Ward
Media
Enquiries
For media enquiries about Professor Sandro Porceddu's areas of expertise, story ideas and help finding experts, contact our Media team: